Your browser doesn't support javascript.
loading
Republication: Targeting PI3KC2ß Impairs Proliferation and Survival in Acute Leukemia, Brain Tumours and Neuroendocrine Tumours.
Boller, Danielle; Doepfner, Kathrin T; Laurentiis, Angela DE; Guerreiro, Ana S; Marinov, Marin; Shalaby, Tarek; Depledge, Paul; Robson, Anthony; Saghir, Nahid; Hayakawa, Masahiko; Kaizawa, Hiroyuki; Koizumi, Tomonobu; Ohishi, Takahide; Fattet, Sarah; Delattre, Olivier; Schweri-Olac, Anelia; Höland, Katrin; Grotzer, Michael A; Frei, Karl; Spertini, Olivier; Waterfield, Michael D; Arcaro, Alexandre.
Afiliación
  • Boller D; Division of Clinical Chemistry and Biochemistry, and University Children's Hospital Zurich, Zurich, Switzerland.
  • Doepfner KT; Division of Clinical Chemistry and Biochemistry, and University Children's Hospital Zurich, Zurich, Switzerland.
  • Laurentiis A; Division of Clinical Chemistry and Biochemistry, and University Children's Hospital Zurich, Zurich, Switzerland.
  • Guerreiro AS; Division of Clinical Chemistry and Biochemistry, and University Children's Hospital Zurich, Zurich, Switzerland.
  • Marinov M; Division of Clinical Chemistry and Biochemistry, and University Children's Hospital Zurich, Zurich, Switzerland.
  • Shalaby T; Department of Oncology, University Children's Hospital Zurich, Zurich, Switzerland.
  • Depledge P; PIramed, Slough, Berkshire, U.K.
  • Robson A; PIramed, Slough, Berkshire, U.K.
  • Saghir N; PIramed, Slough, Berkshire, U.K.
  • Hayakawa M; Drug Discovery Research, Astellas Pharma Inc., Tsukuba, Japan.
  • Kaizawa H; Drug Discovery Research, Astellas Pharma Inc., Tsukuba, Japan.
  • Koizumi T; Drug Discovery Research, Astellas Pharma Inc., Tsukuba, Japan.
  • Ohishi T; Drug Discovery Research, Astellas Pharma Inc., Tsukuba, Japan.
  • Fattet S; INSERM U509, Paris, France.
  • Delattre O; INSERM U509, Paris, France.
  • Schweri-Olac A; Department of Clinical Research, University of Bern, Bern, Switzerland.
  • Höland K; Department of Clinical Research, University of Bern, Bern, Switzerland.
  • Grotzer MA; Department of Oncology, University Children's Hospital Zurich, Zurich, Switzerland.
  • Frei K; Department of Neurosurgery, University Hospital Zurich, Zurich, Switzerland.
  • Spertini O; Service and Central Laboratory of Hematology, Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland.
  • Waterfield MD; PIramed, Slough, Berkshire, U.K.
  • Arcaro A; Ludwig Institute for Cancer Research, Proteomics Unit, London, U.K.
Anticancer Res ; 42(6): 3217-3230, 2022 Jun.
Article en En | MEDLINE | ID: mdl-35641277
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias Encefálicas / Leucemia Mieloide Aguda / Neoplasias Cerebelosas / Tumores Neuroendocrinos Límite: Humans Idioma: En Revista: Anticancer Res Año: 2022 Tipo del documento: Article País de afiliación: Suiza Pais de publicación: Grecia
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias Encefálicas / Leucemia Mieloide Aguda / Neoplasias Cerebelosas / Tumores Neuroendocrinos Límite: Humans Idioma: En Revista: Anticancer Res Año: 2022 Tipo del documento: Article País de afiliación: Suiza Pais de publicación: Grecia